Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, ...

Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...

Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy -- Novigenix AI Liquid Biopsy Platform Identifies Immune Activation ...

Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...

Light has always carried more than brightness. In this case, it also carries direction and twist. That mix may open a new ...

Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...

Grifols (NASDAQ:GRFS) is one of the 10 Overlooked Growth Stocks to Buy Now. Grifols (NASDAQ:GRFS) is one of the overlooked ...

The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selec ...

Environmental risk factors: ADAS sensors degrade under adverse weather and lighting conditions, reducing system reliability.

Unconventional and creatively inspiring, these soft synths are pushing synthesis in bold new directions ...